Streetbeat News

Analyst Ratings

NTES

NetEase (NASDAQ: NTES) receives Buy ratings from Benchmark, Citigroup, and UBS analysts, with price targets raised following the company's upbeat 1Q23 results. The company's game growth is attributed to the strong performance of Eggy Party and legacy titles, with multiple games set to launch in June and Harry Potter: Magic Awakened debuting internationally this summer. NetEase is also focusing on loss reduction and cash flow breakeven for its non-game segments.

Portfolio Pulse from Anusuya Lahiri

May 26, 2023 | 4:10 pm

EVLV

Over the past 3 months, 4 analysts have published their opinions on Evolv Technologies (NASDAQ:EVLV) stock, with an average price target of $6.6, implying an upside from the current price of $5.755. The average price target has increased by 13.79% over the past month.

Portfolio Pulse from Benzinga Insights

May 26, 2023 | 4:03 pm

LOCL

Analysts have provided 5 ratings for Local Bounti (NYSE:LOCL) within the last quarter, with an average price target of $2.8, implying upside from the current price of $0.43. This represents a 70.89% decrease from the previous average price target of $9.62.

Portfolio Pulse from Benzinga Insights

May 26, 2023 | 4:03 pm

DECK

Over the past 3 months, 9 analysts have published their opinion on Deckers Outdoor (NYSE:DECK) stock, with an average 12-month price target of $536.11. The average price target has increased by 8.85% over the past month.

Portfolio Pulse from Benzinga Insights

May 26, 2023 | 4:03 pm

ORCC

In the last quarter, Owl Rock Capital (NYSE:ORCC) received three somewhat bullish ratings and one somewhat bearish rating from analysts. The average 12-month price target for ORCC is $14.0, up 16.67% from the previous average of $12.00.

Portfolio Pulse from Benzinga Insights

May 26, 2023 | 4:03 pm

CMP

Four analysts have provided ratings for Compass Minerals Intl (NYSE:CMP) within the last quarter, with three bullish and one indifferent. The average price target is $53.5, implying an upside from the current price of $33.09. The average has decreased by 7.36% from the previous target of $57.75.

Portfolio Pulse from Benzinga Insights

May 26, 2023 | 4:02 pm

CORT

Over the past 3 months, 6 analysts have published their opinion on Corcept Therapeutics (NASDAQ:CORT) stock, with an average price target of $28.33, representing an upside from the current price of $24.16. The current average represents a 7.11% decrease from the previous average price target of $30.50.

Portfolio Pulse from Benzinga Insights

May 26, 2023 | 4:00 pm

AGEN

EF Hutton analyst Tony Butler reiterates a Buy rating on Agenus (NASDAQ:AGEN) and maintains an $8.3 price target.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 3:58 pm

AYX

ESTC

MDB

MSFT

SNOW

Citi analyst Tyler Radke attended Microsoft Build and was impressed with the company's AI-focused announcements. He reiterated a Buy rating on Microsoft's stock and expects the company to accelerate wallet share gains in the coming quarters. The analyst's takeaways were positive on MongoDB and Elastic, while he sees the Fabric announcement as potentially more disruptive to Snowflake and Alteryx.

Portfolio Pulse from Anusuya Lahiri

May 26, 2023 | 3:58 pm

HIBB

Williams Trading analyst Sam Poser downgrades Hibbett (NASDAQ:HIBB) from Hold to Sell and lowers the price target from $54 to $37.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 3:51 pm